Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease  by Feltes, Timothy F. & Friedman, Richard A.
The incidence of cardioversion-related thr~~Inboem~~ol~sm in 
adult patients with atrial fibrillation is significant (l-4). Eong- 
term anticoagulant pretreatment reduces the risk of these 
emboli, justifying postponement of cardioversion and accep- 
tance of potential therapeutic morbidity (2,5). Transesopha- 
geal ecbocardiograp~ly provides an excellent means of visual- 
izing cardiac structures, including the atria and left atriai 
appendage, where thrombi form as a result of stagnant atrial 
blood flow (6). Manning et al. (7) have recently reported 
success using transesophageal echocardiographic screening for 
atrial thrombi to guide prophylactic anticoagulant therapy in 
these patients. 
In contrast to the adult with atrial fibrillation, the risk of 
postcardioversion embolism in the adult patient with atrial 
flutter is negligible regardless of the patient’s anticoagulant 
status (5). Preliminary transesophageal echocardiographic 
studies in adults with structurally normal hearts indicate that 
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left atrial thrombi are rare (8,‘)). Prccardioversion transesoph- 
ageal echocardiographic screening and prophylactic anticoag- 
ulation would therefore appear to be unwarranted in the 
atient with atrial fluller (10). 
In 1990, a 14”year old boy with surgically repaired tetralogy 
of Fallot and late onset of chronic atrial flutter was referred to 
our institution for elective cardioversion. A transthoracic ccho- 
cardiogram did not reveal an intracardiac thrombus, and left 
ventricular function was assessed as normal. Direct current 
cardioversion was successful, but 16 h after cardioversion, ihc 
patient sukred an acute left middle cerebral artery embo8us 
and ultimately expired This catastrophic case led us to hypoth- 
esize that the incidence of atrial thrombi associated with 
chronic nonfibrillation atrial tachyarrhythmias is increased in 
patients with a congenital heart lesion. To test this hypothesis, 
we prospectively screened for atrial thrombi using transesoph- 
ageal echocardiography in a series of 19 patients wiih C~~OII~C 
atria] tachyarrhythmia and congenital heart disease as they 
presenteci for elecrrophysiologic intervention. 
atjents, Between November 19Yl and November 1993, 
we prospectively evaluated patients with nonfibrillalion atrial 
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Table 1. Demographic and Clinical Characteristics of 19 Sequential Patients With Chronic Atrial 
T&yar@hmia and Congenital Heart Disease Undergoing Transesophageal Echocardiography 
Age Congenital Heart Atria1 
Tee Findings 
Pt No./ 
Gender (yr) Disease Arrhythmia RA Thr LA Thr 
l/M 15.5 PA-IVS; S/P Fontan: Bjork Flutter 
2iM 13.6 Coarctation + MR; S/P MV annuloplasly Flutter 
3/F 40.6 TV atresia; S/P Fontan: conduit Flutter 
4/F 22.3 Congenital hypertrophic cardiomyopathy Flutter + 
5/M 1% Hypoplastic TV, S/P Fontan: Bjork Flutter -1 
6/F 7.2 ASDNSD: SIP repair; advanced PVOD Flutter 
l/M 15.7 TV atresia; S/P Fontan: RA-PA Flutror 
X/F 53.8 ASD; S/P repair Flutrcr + 
‘j/M 25.6 Ehstcin’s; S/P repair Runer + 
IWF 22.3 PA..VSD; S/P Fontau: R&PA Flutter 
I ml 14.8 ASD: S/P repair Fluter _ 
12/M I?.! TV alrrsiil; S/P Follt,llt;~a: Rjork AM Ret -I _- 
13/F 11.2 ‘WA: SIP Musrard rc!pilir Flantes 
I-l/M 23.b Multiple VSDs, S P repalr Flutter _. 
IS/F !N. I PAWS; S/t’ shnnt Flutter . _. 
IWM IT.9 PA”VSD; SIP Fwtan: conduit Flutfrr .c 
I1!M 7.0 TV atrcsia: S/P Fontan: RAmPA Flutter 
In/ 2O.h Ebstein’s, VSD. PAPVR: S/P repair Flutter + 
IWF 43.h TV arrrsia: SIP Fontan: conduit Flutter + 
-__I --e-- 
ASD = atrial scptal defect; AM Rcc = atrial muscle macroreontry tachycardia: F = female; LA Thr = left atrial 
thrombus: M = nlalc: MR = mitralvalve regurgitation; MV = mitral valve; PA-IV’S = pulmonary valve ntresia with intact 
ventricular septum: PAPVR = partial anomalous pulmonary venous return; PA-VSD = pulmonaq valve atresia + 
ventricular septal defect: Pt = patient; PVOD = pulmonary vascular obstructive disease; R&PA = direct right atrium 
to pulmonary artery connection; RA Thr = right utrial thromhus; SIP = status post; Tee = transesoph;~gc;~l 
echocardiographic;TGA = simple transpositbn of great artcries; TV = tricuspid val\le: VW = vwtricular sepIaI drfcct: 
tachyarrhythmia and conpnital heart disease who were admit- 
ted to the Texas Children’s Hospital for clectivc ardiovcrsion 
or radiofrequcncy ablation. As a requirement for inclusion i  
the study, the arrhythmia hnd to ~WC pcrsistcd for a minimum 
of 48 h before the anticipated clcctrophysiologic intervention 
on the basis of electrr~ilrdiogrilphic documentation or abrupt 
onset of symptoms. Similar minimal duration criteria have 
been used in adult patient arrhythmia studies investigating 
their association with atria1 thrombi (5). Patients who had 
ustdergone surgical palliation or repair of their congenital: 
hrart disease within the past 6 months were excluded. 
Nineteen consecutive patients (median age 19.6 years, 
range 7to 53.t1;  I male, 8female) fulfilled enro!lment criteria 
for the study (Table 1). All eligible patients ortheir families, or 
both, gave informed consent and agreed to participate. Pa- 
tients with tachyarrhythmias included 18 with atria1 flutter and 
1 with primary atrial tachycardia thought to be consistent with 
atria1 muscle reentrant tachycardia. P tients with congenital 
heart lesions i cluded IO with right heart obstructive lesions 
(tricuspid/pulmonary v lve stenosis/atresia); 4 with septal le- 
sions (atrialiventricular); 2 with an Ebstein’s malformation f 
the tricuspid valve; and 1 each with congenital hypertrophic 
cardiomyopathy, ransposition f the great arteries and aortic 
coarctation with mitral valve regurgitation. Eighteen of the 19 
patients had previously undergone palliative or corrective 
cardiac surgery. Nine patients had undergone a Fontan repair, 
all performed before 1987. Among these nine patients, three 
had roofing of the right atr~~~~ andright ventrick to the 
onary artery (Fontan: Bjork), three had a direct right 
atria1 to pulmonary artery connection (Fontan: right atrium to 
pulmonary artery), and three bad a rig& atrial to pulmonary 
artery conduit (Fontan: conduit). None of the nine patients 
with a Fontan repair had a total cavopulmonary connection. 
Other corrective surgeries included r pair of an Ebstein’s 
malformation (two patients); repair of atrial or ventricular, or 
both, septal defects (four patients), Mustard repair for correc- 
tion of simple transposition of the great arteries (one patient), 
coarctectomy with mitral valve replacement (one patient) and 
palliative systemic topulmonary arterial shunt (one patient). 
Echocardiographic technique. Complete transthoracic 
echocardiograms, including two-dimensional imaging, Doppler 
study and assessment of systolic ventricular function, were 
performed in the echocardiography laboratory before the 
planned electrophysiologic intervention. Particular attention 
W.G paid to ruling out intracardiac thrombi. Transesophageal 
examinations were performed in either the cardiac atheter- 
ization laboratory orthe intensive care unit. In anticipation f 
either direct current cardioversion or radiofrequency ablation, 
all patients underwent general nesthesia forthe examination. 
We used Acuson, Vingmed (Vingmed Sound) or lnterspec 
transesophageal echocardiographic ediatric oradult 58MHz 
probes for the examinations. The right and left atria1 cavities 
were scanned in the basal short-axis and transgastric four- 
chamber (longitudinal a d transverse) views for evidence of 
‘gable 2. Clinical and Echocardiographic Characteristics of 19 
Patients ithout Transesophageal ~e~~~c~r~ia~ra~~~~c 
ence of an Atrial Thromhus 
m 
Th~OUlhkJS No fhromhus 
(n = 8) (n = II) 
No. of No. of P 
Pts 9 Pts !“r VdUe 
atrial thrombi. Intracardiac masses were considered thrombi if 
they appeared well ~i~~~~~is~~ibed wit 
and were distinct from the atria1 wall. Although spontaneous 
atrial contrast was also noted in each patient, its presence was 
considered an indication of blood stasis but not a cardiogenic 
source of thromboembolus. All transthnracic and transzsoph- 
ageal echocardiographic studies were viewed by a minimum 
of two experienced echocardiographers, and presence of an 
acteristics were tested for their association with atrial thrombi: 
patient age, gender, presence of extensive atrial surgery (yes vs. 
no), duration of arrhythmia (~7 vs. >7 days), presence of 
spontaneous atrial contrast (yes vs. no) and status of systemic 
ventricular function (good-fair vs. poor) as evidenced by 
echocardiography. Poor ventricular function was defined as 
evidence of marked global hypokinesia. Extensive atrial sur- 
gery included all patients with Fontan repair as well as those 
requiring patch closure of an atrial septal defect or interatrial 
baftling (Mustard repair). 
Statistical andysis. Data are expressed as mean value t 1 
SD. Patients were grouped by the presence or absence of an 
atrial thrombus detected by transesophageal chocardiogra- 
phy, and the differences between groups were analyzed. Age 
difference between patient groups was tested by a simple 
Mann-Whitney U test. Other patient and echocardiographic 
characteristics were tested by contingency table analysis, with 
the p value determined by a Fisher exact test; p 5 0.05 was 
considered statistically significant. 
Figure 1. Massive right atrial thrombus (4.5 X 3.5 em) in an M-year 
old man (Patient 16) with pulmonary valve atresia after Fontan repair. 
Marked spontaneous right atrial contrast and poor ventricular function 
were noted in this patient. IAS = interatrial septum: LA = left atrium. 
All I9 patients were successfully studied by transesophageal 
cchocardiography before clcctrophysinlogic intervention. 
There were no interobserver discrepancies in the interpreta- 
tion of the echocardiograms, and no procedural com~licatio~~s 
were encountered. 
bus on transesophageal xamination (Table 1). Of the 10 
transthoracic echocardiographic examinations available for 
this group of patients, there were no false positive findings for 
atrial thrombus. The average age of this group of patients was 
18.2 of: 9.9 years and included six male and five female patients 
(Table 2), all of whom had atrial ilutter. After transesophageai 
echocardiographic screening, all I I of these patients wenl on 
to have successful e ectrophysiologic intervention (direct cur- 
rent cardioversion i 9, radiofrequency ablation in 1. sponta- 
neous cardioversioll i 1 1) without complication. There w  no 
late thromboembol;: events. 
raphy. There were eight solitary atrial thrombi dentified by 
transesophageal chocardiography, for an overall incidence of 
42% (Table I). Six of the eight thrombi were identified in the 
right atrium (Fig. l)? and two were located in the left atrium 
(Fig. 2). Sevell of the eight patients with atria1 thrombi had 
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., 
8~2. Left atria1 (IA) throw 
into, the left atrial ppendage (LAA) in w 54.year old woman (Patient 
8) with atrial flutter who underwcnr repair of an utriul septal defect 35 
yean earlier und had poor left ventricular functian. 
been ~~~re~~e~ by transthoracic eehocardi 
these patients, the transthoracic echocardiogr 
for an intracardiac thrombus, and one right atria1 thrombus 
was identified by transthoracic ech~~~io~raphy. T e average 
up of patients was 26.9 2 I4.2yean.r and included 
three female patients (Table 2). Eight patients 
arrhythmias, including seven with atrial flutter and one 
atrial tachyarrhythmia. Operative procedures 
tients included four patients with Fontan repair 
(Fontan: Bjork in two, Fontan: canduit in two), two with 
ein’s malformation repairs: one with atria1 septal defect 
it; there was one patient with congenital hypertrophic 
No patients subsequently underwent clectrophysiologic 
~~~~dures at the time of thrombus detection. One patient 
ient S), who had a dual-chamber transvenous pacing 
system already implanted, had attempted atrioventricular node 
radiofrequency ablation. A second patient (patient 19) who 
presented with a transient ischemic attack and had already 
been pretreated with oral anticoagulants for 4 weeks before 
the electrophysiologic study, underwent uncomplicated direct 
current cardioversion. 
Electrophysiologic procedures were deferred in six of the 
eight patients with thrombus. Ah six were discbarged wit 
warfarin therapy after adequate a~t~coago~atio~ bad 
estatlished. After 4 to 6 weeks of oral warfarin, all s 
deferred patients were reevaluated for c~~dioversi~~. T 
these patients underwent successful direct current cardiover- 
taneous atria! contrast 
patients were success- 
The extent of the atrial sur 
ta~eous atrial co~~tr~lst 
four of the five patients th poor ventricular function bad 
atrial thr~mbi id~uti~ed. spite these findings, the associa- 
tion between poor ventr lar function and atrial thro 
failed to achieve statistical s~~~ifica 
ended survival of cbildre~ with congenital heart disease 
ha n achieved through improved patient preparation along 
with advances in traoperative my~ardial protection and 
ical techniques. With ~ontinMed efforts to improve survival 
and quality of life for these patients come the challenges of 
long-term complications. Management of atrial flutter has 
become a recurrent dilemma inthe patient who has undergone 
the Fontan repair for treatment of univentricular heart (11). In 
this study, we demonstrated a 42% incidence ofatrial thrombi 
in a prospectively screened series of patients with congenital 
heart disease and nonfibrillation atrial tachyarrhythmias, the 
majority of whom had undergone a modified Fontan repair. 
We believe that our study is the first to associate prothrombic 
conditions with atrial flutter or a flutter-like arrhythmia in the 
patient with cougenital heart disease and reconfirms the 
superiority of transesophageal imaging for the detection f 
atrial thrombi (7,12,13). Of the eight solitary atrial thrombi 
detected by transesophageal echocardiography, two were iden- 
tified in the left atrium (11% incidence), and six (75% of the 
thrombi detected) were located in the right atrium (32% 
incidence). These findings compare with those reported by 
Manning et al. (7) in a similarly designed prospective study in 
which adults with atria1 fibrillation and structurally normal 
hearts underwent precardioversion transesophageal echocar- 
ter and a structur- 
he&s is that, unlike the “atrial stunning” that results from 
demonstrated in adults with either atrial fibrillation or mitral 
valve disease (7,18,19). In our series of patients with congenital 
heart lesions, the potential for atrial dilation and stagant blood 
flow existed on either side of the atrial septum. Depressed left 
ventricular systolic (Patients 2,8,9,16, 19) or diastolic (Patient 
4) function or left atrial hypertension from mitral valve disease 
(Patient 2) would be expected to favor stagnant left atrial 
blood flow (9,18,19). By contrast, right atrial blood flow stasis, 
may be expected in patients with right atrial hypertension after 
a Fontan or Ebstein malformation repair, car pulmonale or 
right ventricular dysfunction (Patients 1, 3,5 to 7,9, 10 to 13, 
15 to 19) (23). Unfortunately, atrial dimensions cannot be used 
as predictive variables for thrombus formation in patients with 
congenital heart disease because atrial geometry varies greatly 
as a function of structural disease. 
Our hypotkesis that atrial blood flow stagnation occurs in 
patients with nonfibrillation atrial tachyarrhythmia and con- 
genital heart disease was perhaps most strongly supported by 
the frequent observation of spontaneous atria1 contrast in our 
contrast is an ~~~~sa~~j~~~~ 
discrete cho refiectances pre 
that creates a s~~~rl~~g appearance 
rence of atria1 thro 
o~se~ed s~o~ta~eo~s echo contrast in five 
ion. Hn each of these 
to the thrombu 
,19) and co~tralateral in one ( 
Gents with s~o~ta~eo~s atria1 
ilated as a result of the 
‘tal disease and surgical re 
nts, Ebstein’s malformation 
lack et al. (9,27), we observed a
unction among our patients 
to achieve statistical signif- 
icance as a risk factor for atri < 0.07), 
poor ventricular function was ems with 
atrial thrombi versus just 1 o thrombi. 
These data support he concept hat thrombus risk factors may 
itive in the patient with ~omfibrillation atrial tachyar- 
Early postoperative thrombus complications and their rela- 
tion to arrhythmia have been reported in children undergoing 
the Fontan procedure. but we believe lhet this is tile first report 
of long-term complications of atria? thrombi n this group of 
patients (28.29). The risk of p~~rno~ary embolus may have 
significant bemodynamic consequences for the patient with a 
Fontan or Ebstein’s rnalf~~~rnation , diagnoses common 
atients with right-s 
iac output in the 
dependent on low pu~mona~ vascular esistauce (30). Even 
partial occlusion of the pulmonary arterial bed occurring as a 
result of thromboembolization of aright atrial thrombus could 
result in significant morbidity. Modifications of the Fontan 
procedure hav ved since the initial description of this 
t sonnections from the right atrium tothe 
pulmonary artery have generally given way to cavopulmonary 
diversion in an effort to unload the compliant right atrium 
which, as it dilates over time, becomes ineffective as a pump to 
the pulmonary circuit. The findings of our study raise further 
concern for the patient with classic (right atrium topulmonary 
artery connection), conduit (complete or partial from right 
atrium to pulmonary artery) or 
ntricle connection) modifications 
wever, the long-term complicati 
diversion remain to be seen. 
e study. Our findings fail to define a 
course of action for precardioversion a ticoagulation therapy. 
We are uncertain whether the risks of delayed antiarrhythmia 
management and anticoagulation therapy were justified be- 
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cause we cannot conclude whether or not our therapeutic 
approach ad any significant bearing on outcome. Without 
studies to assess baseline and postcardioversion lungperfusion, 
we cannot be assured that embohzation had not occurred in 
our patients who had anticoagulation after identification f 
right-sided thrombi. Furthermore, we cannot be certain that 
the risk of a cardioversion-related thromboembolic event is 
negligible on the basis of negative findings on transesophageal 
echocardiographic screening (21). Still, our experience indi- 
cates that transesophageal echocardiographic screening for 
intracardiac thrombi and current treatment strategies arc safe 
and informative. 
velopment of atrinl thrombi occurs fre- 
quently in the patient with nonfibrillation atrial tachyarrhyth- 
mia and congenital heart disease. The risk of t~~ombus forma- 
tion may be compounded by the presence of atrial dilation and 
severe ventricular dysfunction. Continued tra~seso~ha~ea~ 
cchocardiographic screening of these patieuts i warranted to
identify risk factors and to address therapeutic eticacy. 
We express our appreciation to Nancy Ayres, MD, Tal Gcva, MD, Acbi 
Ludominky. MD, Riardo Pignutclli, MD and 6. Wesley Vick, MD for their 
ndstance in tbc coilcction and analysis of the data. 
rices 
I. riesnckw L. McDonald L. Complications in 220 patients with cardiac 
dysrhythmias treated by phased direct current shock. and indications for 
clec:roeardioversion. Br Heart J i967%926-36. 
2. Bjerkelund C, Oming G. The ctlicacy of anticoagulant therapy in prcvcnting 
emhulism rclatcd to DC clcctrical cardioversion of atrial fibrillation. Am .J 
Curded i%%?J:?M-16. 
3. Peterson P. Godtfrcdsen J. Embolic complications in paroxysmal atrial 
fibrillation. Sti-okc 19*% 1716224. 
4 Weihcrg D, Mancini G. Anticoagulation for cardioversion of atrial tibrilla. 
tion. An1 3 Cardid l989$13:445-0. 
5. Xeciler Arnold A, Mick M. Mururek R. Loop F, Trohman R. Role of 
prophylactic anticuapktion for direct current cardioversion in patients with 
atri4 fibrillation or atrinl flutter. J Am Coil Qrdiol 199?:19:8S14. 
& Rollick C. Taylor B. Asswmcnt of bh atrial appendage function by 
t~n~~~u~cal echocardiq;qhy: implications for the development of 
*hromhus. Circulation I9%4:223-11 . . 
1. Mawing W. Silverman D, Gordon S, Krumholz H, Douglas P. Cardiovcr- 
sion from atria1 fibrillation without prolonged anticoanulation with use of 
lr~n~~~~~~~l cx-hocardiography to~exclud;: the presc& of atrial thrombi. 
N Ennl J Med pI93:328:750-5. 
S Sat&go 0, Warshofskv M, Mandri G, et al. Left atriril appendage function 
thrombus form&n in atrial flutter [abstract]. Circulation 1993:88: 
Suppl 1:1-19. 
9. Black 1. Hopkins A. Lee L, Walsh W. Evaluation of transesophagcal 
c&ocardiiraphy bcforc cardiovcrsion of aerial fibrillation and tluttcr in 
nonanticoagulatcd patients. Am Heart 3 1993:126:375-Hi. 
10. 
ii. 
12. 
13. 
14 
is. 
lb. 
17. 
IN. 
IY. 
Daniel W. Should transesophageal echocardiograpby be used TV guide 
cardioversion? N Engl J bled 1993;328:8K3-4. 
Garson A, BinkBoelkens M, Hesslein P, et al. Atrial flutter in the young: a 
collaborative study of 380 cases. J Am Coil Cardiol 1965$:871-8. 
Miigge A, Daniel W, Hausmann D. Giidke J, Wagenbreth I, Lichtkn P. 
Diagnosis of noninfective cardiac mass lesions by two-dimensional ecbocar- 
diography: comparison of uansthoracic and tramesophageal approaches. 
Circulation 1991;83:70-8. 
Black I, Hopkins A, Lee L, Walsh W. Role of transcsopbageal ecbocardi- 
ography in evaluation of cardiogenic embolism. Br Heart J 199i;Gt?302-7. 
Halperin JL, Hart RG. Atrial fibrillation and stroke: new ideas. pcrsistiag 
dilemmas. Stroke 198&19:937-41. 
Special Report: Prelimin~ report of the stroke prcvcution in atrial 
fibrdlation study. N Engl J Med. I 
Pa&i M, Febo 0, Torbicki A. L *: al. Left atrial ;ip~C~a~~~C dgsfunstion: a 
cause of thrombosis’? Evidcncc by ~rat~sesopl~ageal ec~~~~c~~~d~~~ra~~~y 
Doppler studies. J Am Sot ~ch~~ar(~io~r 199~;~:~3~-~~. 
M’iggc A, Kuhn II, Grate J, Lopez A, Daniel W. Assessment uf kft atria! 
iip~tdi@C function by biphinc tr~~~t~~(~plta~eal cclt(~ardi[l~rilphy in pa 
dcnls witb noitrhe~ntiltic atrial ~bril~~lt~~~l~: ~d~~t~~~citt~~~a of a subgroup of 
patients at increased embolic risk. J Am Coil Cardiol l*~9~23:~(~-~~~, 
Casfello R. l’carson A, Lahovitz A. Prcvalcncc aad clinical ir~tp~ici~t~~)~ts of
atrial spontaneous contrast in patients undergoing transcsophagcal c&car- 
diography. Am J Cardid 1~~~~ 149-53. 
Vigna C. Rito V. Criconiu 6, et al. Left atrial ~hrombus and spontmm~s 
cchocontrast in nonanticoagulated mitral stenosis: it transes(lplta~cal echo- 
cardiographic study. Chest 1993;103:338-52. 
20. Roy D. Marchand E, Gagne P, Chabot M, Carticr R. Usefulness of 
anticoagulant therapy in tile prcvcntion of cmbolic complications of atrial 
fibrillation. Am Hcrrt J 198h:t 12:1039-4X 
21. Grimm R. Klein A, Stcwxt W. et aI. Why arc patients with iurial gutter less 
susceptibtc to systemic embolization following cardiovcnion than those with 
atrial fibrill:!iion? [abstract]. Circuhttion l992$6 Suppl I:I-f&3. 
22. C~~r~~~~~n R. Arriaqada D, Draun S, ct al. Risk hCtoD for systemic embolism 
in patients with paktxysmai atriai ~b~l~ation. Am bbxrt J. 199~124:139-53. 
23. Boulay E Dancltin N, Neimann J-L. Godenir J-P. Mottppc J-P. Echocardio- 
graphic fcaturcs of right ihll thromhi. J Clio Ultrasound 19S6:13:h01-6. 
24. Black I, Hopkins A. Lee L Walsh W. Left atrial spontaneous rcho contrast: 
a clinical cch~ar[~i~~~r~lPhic analysis. J Am Coil Cardiol 1991; 18:398-40.4. 
5. Black I, Chesterman C. Hopkins A. Lee L Chg B, Walsh W. Hematologic 
corrclatcs of left atrial spontancou~ echo contrast and thromboemholism in 
nonvalvar atrial tibrill&m. J Am CoII Cardiol i1N3:Zl:4S t-7. 
26. Iliceto S. Antonclli G. Sorino M, Biasco G. Rizzon P. Dynamic intracavitary 
left atrial echoes in mitral stenosis. Am J Cardiol 19RS:35:603-6. 
27. Black 1. Stewart W. Walsh W. et al. Location of left atrial thrombi 
(appendage vs cavity) 15 dependent on underlying cardiac disease [abstract]. 
J Am Colt Car:,iol i~3~2~:2~A. 
28. PCtct-, N, !ionrcr.ille J. hr:hythmias after the Fontan procedure. Br Heart J 
1992$&19%?9=t. 
29. Fyfe D. Kline C, Sade R. Gillette P. Transesophageal echocardiography 
detects thrombus formation not identified by transthoracic echocardiography 
after the Fontan operation. J Am Coll Cardiol 1991;18:1733-7. 
30. Bridges N. Farrell P, Piptt J. Nonvood W. Chin A. Pulmonary artery index: 
a nonpredictor of operative survival in patients undergoing modified Fontan 
repair. Circulation 1989:80: Suppl [:I-2ih-21. 
31. de Leval M. Kilner P, Gewillig M. Bull C. Total cavopulmonary connection: 
a logical alternative to atriopulmonary connection for complex Fontan 
operations. J Thordc Cardiovasc Surg 198R:9h:hRZ-95. 
